Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-14 4:55 pm Purchase | 2023-12-31 | 13G | Kiora Pharmaceuticals, Inc. KPRX | Lincoln Park Capital Fund LLC | 260,731 9.990% | 251,618 (+2761.26%) | Filing History |
| 2024-02-14 4:32 pm Sale | 2023-12-31 | 13G | X4 Pharmaceuticals, Inc. XFOR | Lincoln Park Capital Fund LLC | 1,600,136 0.947% | -209,951 (-11.60%) | Filing History |
| 2024-02-14 4:31 pm Sale | 2023-12-31 | 13G | TRACON Pharmaceuticals, Inc. TCON | Lincoln Park Capital Fund LLC | 5,841 0.375% | -112,650 (-95.07%) | Filing History |
| 2024-02-14 4:31 pm Sale | 2023-12-31 | 13G | Ensysce Biosciences, Inc. ENSC | Lincoln Park Capital Fund LLC | 8,267 3.792% | -72 (-0.86%) | Filing History |
| 2024-02-14 4:30 pm Sale | 2023-12-31 | 13G | Windtree Therapeutics, Inc. WINT | Lincoln Park Capital Fund LLC | 377 6.181% | -133 (-26.11%) | Filing History |
| 2024-02-14 4:29 pm Purchase | 2023-12-31 | 13G | Cellectar Biosciences, Inc. CLRB | Lincoln Park Capital Fund LLC | 1,307,049 9.676% | 369,461 (+39.41%) | Filing History |
| 2023-06-02 4:46 pm Purchase | 2023-05-31 | 13G | TRACON Pharmaceuticals, Inc. TCON | Lincoln Park Capital Fund LLC | 118,491 8.980% | 118,491 (New Position) | Filing History |
| 2023-04-24 4:33 pm Purchase | 2023-04-20 | 13G | Windtree Therapeutics, Inc. WINT | Lincoln Park Capital Fund LLC | 510 9.990% | 510 (New Position) | Filing History |
| 2023-02-06 6:34 pm Purchase | 2023-02-02 | 13G | Ensysce Biosciences, Inc. ENSC | Lincoln Park Capital Fund LLC | 8,339 9.990% | 8,339 (New Position) | Filing History |
| 2022-10-25 06:01 am Purchase | 2022-10-21 | 13G | Cellectar Biosciences, Inc. CLRB | Lincoln Park Capital Fund LLC | 937,588 9.990% | 706,220 (+305.24%) | Filing History |
| 2022-07-28 5:09 pm Purchase | 2022-07-26 | 13G | Kiora Pharmaceuticals, Inc. KPRX | Lincoln Park Capital Fund LLC | 9,112 9.990% | 9,112 (New Position) | Filing History |
| 2022-05-18 12:34 pm Purchase | 2022-05-17 | 13G | Vallon Pharmaceuticals, Inc. VLON | Lincoln Park Capital Fund LLC | 35,008 9.990% | 35,008 (New Position) | Filing History |
| 2022-04-27 10:52 am Purchase | 2022-04-22 | 13G | Salarius Pharmaceuticals, Inc. SLRX | Lincoln Park Capital Fund LLC | 14,849 5.980% | 14,849 (New Position) | Filing History |
| 2022-01-19 11:05 am Purchase | 2022-01-14 | 13G | X4 Pharmaceuticals, Inc. XFOR | Lincoln Park Capital Fund LLC | 1,810,087 6.440% | 1,810,087 (New Position) | Filing History |
| 2021-11-19 12:57 pm Purchase | 2021-11-12 | 13G | Nabriva Therapeutics plc NBRVF | Lincoln Park Capital Fund LLC | 180,504 7.960% | 180,504 (New Position) | Filing History |
| 2021-04-28 5:22 pm Purchase | 2021-04-28 | 13G | Benitec Biopharma Inc. BNTC | Lincoln Park Capital Fund LLC | 24,913 5.392% | 24,913 (New Position) | Filing History |
| 2021-01-15 6:21 pm Purchase | 2021-01-14 | 13G | Viveve Medical, Inc. VIVE | Lincoln Park Capital Fund LLC | 701,000 9.990% | 701,000 (New Position) | Filing History |
| 2021-01-08 4:38 pm Purchase | 2021-01-07 | 13G | Onconova Therapeutics, Inc. ONTX | Lincoln Park Capital Fund LLC | 909,294 6.520% | 909,294 (New Position) | Filing History |
| 2020-11-13 06:01 am Purchase | 2020-11-12 | 13G | Moleculin Biotech, Inc. MBRX | Lincoln Park Capital Fund LLC | 53,192 7.520% | 53,192 (New Position) | Filing History |
| 2020-08-03 4:03 pm Purchase | 2020-08-03 | 13G | Advaxis, Inc. ADXS | Lincoln Park Capital Fund LLC | 57,435 6.940% | 57,435 (New Position) | Filing History |